Publication

Phase 1 Study of Multiple Intracerebral Doses of a Neural Stem Cell-based Oncolytic Virotherapy for Treatment of Recurrent High-grade Gliomas

ASCO Annual Meeting 2024

Calidi Biotherapeutics

A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.

Learn more

A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.

Learn more